Surgery After Myocardial Infarction: Timing, Risk & Guidelines
Elective non-cardiac surgery after myocardial infarction (MI) carries elevated perioperative cardiac risk. Timing depends on MI acuity, revascularization, and clinical stability.
Risk Stratification by Timing
| Time Since MI | Perioperative MACE Risk | Recommendation |
|---|
| <30 days | Very high (15–30%+) | Delay elective surgery; only emergency/lifesaving |
| 30–60 days | High | Defer if possible; optimize medical therapy |
| 60–90 days | Moderate | Individualize; cardiology clearance |
| >90 days | Baseline (if stable) | Proceed with standard risk assessment |
Key Factors
- Revascularization status: PCI with stent → dual antiplatelet therapy (DAPT) timing critical. Bare-metal stent: ≥1 month; DES: ≥6 months (ideally 12) before elective surgery.
- LVEF, heart failure, arrhythmias: Increase risk independently.
- Surgery urgency/type: High-risk surgery (vascular, major abdominal, thoracic) vs. low-risk (cataract, superficial).
Perioperative Management
- Continue aspirin; manage P2Y12 inhibitor per stent timeline/surgery bleed risk.
- Beta-blocker continuation (not routine initiation de novo).
- Statin continuation.
- Hemodynamic monitoring, troponin surveillance post-op.
Multidisciplinary discussion (surgeon, anesthesiologist, cardiologist) is essential for recent MI.
Open Heart Surgery - Related Articles
